Healthcare - Biotechnology - NASDAQ - US
$ 86.83
-6.31 %
$ 10.8 B
Market Cap
-18.88
P/E
Price Target
Average
58.29%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
0.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vaxcyte, Inc.
Wall Street analysts predict an average 1-year price target for PCVX of $137 , with forecasts ranging from a low of $98 to a high of $163 .
PCVX Lowest Price Target
Wall Street Target
98 USD
12.86%
PCVX Average Price Target
Wall Street Target
137 USD
58.29%
PCVX Highest Price Target
Wall Street Target
163 USD
87.72%
REVENUE FORECAST
Revenue Forecast Chart PCVX
EBIT FORECAST
EBIT Forecast Chart PCVX
NET INCOME FORECAST
Net Income Chart PCVX